We Are Building a Future Free of Age-Related Disease

SENS Research Foundation works to develop, promote, and ensure widespread access to therapies that cure and prevent the diseases and disabilities of aging by comprehensively repairing the damage that builds up in our bodies over time. We are redefining the way the world researches and treats age-related ill health, while inspiring the next generation of biomedical scientists.

Discover the science behind our strategies to extend a healthy lifespan.

Training a new generation of scientists to tackle the roots of age-related disease.

Keep up to date on SRF’s latest news and activities.

Outreach Highlights -

We are incredibly excited to officially share that SENS Research Foundation and Lifespan.io will be joining forces, upon completion of regulatory approvals, coming together to form a new and unique longevity nonprofit that deliberately aligns longevity research with powerful advocacy. 

With a redoubled focus on impactful and translatable research, the merged organization will serve a key sense-making and unifying role for the longevity industry, accelerating the development, translation, and equitable distribution of therapies to increase healthy human lifespan for everyone. 

With our complementary strengths and shared vision, we are excited to move forward together as a united front, towards a future where aging is no longer a barrier to a life well lived. 

Thank you for being with us on this journey!


SRF is thrilled to be partnering with XPRIZE Healthspan – a 7-year, $101 million global competition to revolutionize the way we approach human aging.

The launch of the XPRIZE Healthspan is a milestone eagerly anticipated by SENS Research Foundation, as it represents a pivotal moment in the longevity industry. SRF is eager to support XPRIZE, with is unparalleled ability to foster global innovation through competition.

SENS Research Foundation is thrilled to walk for Parkinson’s Disease while partnering with the Parkinson’s Foundation on Moving Day, April 20th, 2024.

Join us in this walk for life at Lake Cunningham Regional Park in San Jose, where SRF will be participating with our team showing support for the progress in research on Parkinson’s disease, a condition representing one of the major age-related diseases and one our research aims to address.

All funds raised that day will be used to advance Parkinson’s disease research, increase access to quality care, and provide education and outreach initiatives to people with Parkinson’s, while raising awareness.

Show your support by joining the SRF team on Moving Day or by purchasing a T-shirt. All proceeds are directed to the Parkinson’s Foundation.

Research Highlights -

SRF is a proud sponsor of the Phaedon Institute’s Seno-Therapeutics Summit 2023. Dr. Amit Sharma spoke at the Summit – his presentation was entitled, “Next-generation Senotherapeutics: From harnessing the immune system to targeting newer vulnerabilities of senescent cells.

The summit was hosted by the Buck Institute For Research On Aging in Novato, CA. Entitled Seno-Therapeutics: Past, Present & Future of the Science of Cellular Senescence and Therapeutics, the summit was held November 7-8, 2023.

Education Highlights -

Thank you to the University of San Francisco, UNC at Chapel Hill, and the University of Miami for allowing us to participate at your in-person and virtual career fairs this past month!

Thank you to Kriti, Michael, and Kartik for their presentation during our education hour!

Congratulations Laura Lin, our 2024 Post-bacc speed talk champion! And thank you to all our students for their outstanding speed presentations! 

SRF is proud to be funding a Summer Scholar program for Afrolongevity – a nonprofit subsidiary project of the Transdisciplinary Agora for Future Discussions (TAFFD.) The organization avails systemic approaches for understanding, translating, and educating Africans on the ethical methods of achieving a healthy life span.

SRF will be fund one student for this Summer Scholar program, chosen by Afrolongevity’s committee. The student will be placed in an African laboratory that focuses on aging and longevity. This same student will also be flown to Afrolongevity’s annual conference in 2024.



AmyloSENS Therapies for Alzheimer’s: The Marathon and the Decathlon

The Phase III trials for AmyloSENS rejuvenation biotechnologies lecanemab/Leqembi® and donanemab showed that they are most effective when given to people with less of other kinds of cellular and molecular aging damage in their brains. New data illustrates that fact even more powerfully and gives us a foreshadowing of what’s possible if we make best use of these and forthcoming damage-repair longevity therapeutics.

Use of this Web site constitutes acceptance of the Terms of Use and Privacy Policy.

© 2024 SENS Research Foundation – ALL RIGHTS RESERVED

Thank you for Subscribing to the SENS Research Foundation Newsletter.

You can also


You can

SENS Research Foundation Audience Survey

And follow the link at the end to WIN!: